Characterization of PTPN2 and its use as a biomarker

Methods

Volumn 65, Issue 2, 2014, Pages 239-246

  Bussières Marmen, Stéphanie ^a,b   Hutchins, Andrew P ^c   Schirbel, Anja ^d,e   Rebert, Nancy ^d   Tiganis, Tony ^f   Fiocchi, Claudio ^d   Miranda Saavedra, Diego ^c   Tremblay, Michel L ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c OSAKA UNIVERSITY   (Japan)

^d LERNER RESEARCH INSTITUTE   (United States)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f MONASH UNIVERSITY   (Australia)

Author keywords

Alternative splicing; Monoclonal antibodies; PTPN2 isoforms; RNA sequencing; SiRNA; SNP genotyping

Indexed keywords

BIOLOGICAL MARKER; ISOENZYME; MESSENGER RNA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2;

ALTERNATIVE RNA SPLICING; ARTICLE; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME MODIFICATION; GENE LOCUS; HUMAN; INFLAMMATORY BOWEL DISEASE; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATORY MECHANISM; RNA SEQUENCE; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STOICHIOMETRY; TISSUE SPECIFICITY;

ALTERNATIVE SPLICING; MONOCLONAL ANTIBODIES; PTPN2 ISOFORMS; RNA SEQUENCING; SIRNA; SNP GENOTYPING;

ANIMALS; BIOLOGICAL MARKERS; CATALYTIC DOMAIN; CROHN DISEASE; EVOLUTION, MOLECULAR; HUMANS; MICE; PHYLOGENY; PROTEIN ISOFORMS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; RNA, MESSENGER; SEQUENCE ALIGNMENT; T-LYMPHOCYTES;

EID: 84892892340     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2013.08.020     Document Type: Article

References (42)

1. Hardy S., Julien S.G., Tremblay M.L. Anti-cancer Agents in Medicinal Chemistry 2012, 12(1):4-18.
2. Julien S.G., Hardy S., Tremblay M.L. Nature Reviews Cancer 2011, 11(1):35-49.
3. Stuible M., Doody K.M., et al. Cancer and Metastasis Reviews 2008, 27(2):215-230.
4. Rhee I., Veillette A. Nature Immunology 2012, 13(5):439-447.
5. Mustelin T., Vang T., Nunzio B. Nature Reviews Immunology 2005, 5(1):43-57.
6. Doody K.M., Bourdeau A., et al. Immunological Reviews 2009, 228(1):325-341.
7. Nature 2007, 447:661-687. The Wellcome Trust Case Control Consortium.
8. You-Ten K.E., Muise E.S., et al. The Journal of Experimental Medicine 1997, 186(5):683-693.
9. Loh K., Merry T.L., et al. Diabetologia 2012, 55(2):468-478.
10. Zee T., Settembre C., et al. Molecular and Cellular Biology 2012, 32(6):1080-1088.
11. Wiede F., Shields B.J., Chew S.H., Kyparissoudis K., Van Vliet C., Galic S., Tremblay M.L., Russell S.M., Godrey D.I., Tiganis T. Journal of Clinical Investigation 2011, 121(12):4758-4774.
12. Heinonen K.M., Nestel F.P., et al. Blood 2004, 103(9):3457-3464.
13. Bourdeau A., Trop S., et al. Stem Cells 2013, 31(2):293-304.
14. Galic S., Hauser C., et al. Molecular and Cellular Biology 2005, 25(2):819-829.
15. Loh K., Fukushima A., Zhang X., Galic S., Briggs D., Enriori P.J., Simonds S., Wiede F., Reichenbach A., Houser C., Sims N.A., Bence K.K., Zhang S., Zhang Z.-Y., Kahn B.B., Neel B.G., Andrews Z.B., Cowlet M.A., Tiganis T. Cell Metabolism 2011, 14(5):684-699.
16. Cool D.E., Tonks N.K., Charbonneau H., Walsh K.A., Fischer E.H., Krebs E.G. Proceedings of the National Academy of Sciences 1989, 86:5257-5261.
17. Champion -Arnaud P., Gesnel M.C., Foulkes N., Ronsin C., Sassone-Corsi P., Breathnach R. Oncogene 1991, 6(7):1203-1209.
18. Mosinger B., Tillmann U., et al. Proceedings of the National Academy of Sciences 1992, 89(2):499-503.
19. Sakaguchi A.Y., Sylvia V.L., Martinez L., Smith E.A., Han E.S., Lalley P.A., Shows T.B., Choudhury G.G. Genomics 1992, 12(1):151-154.
20. Johnson C.V., Cool D.E., Glaccum M.B., Green N., Fischer E.H., Bruskin A., Hill D.E., Lawrence J.B. Genomics 1993, 16(3):619-629.
21. Lin W.A., Pawson T. Cell 2010, 142(5):661-667.
22. Andersen J.N., Mortensen O.H., et al. Molecular and Cellular Biology 2001, 21(21):7117-7136.
23. Buszard B.J., Johnson T.K., et al. Molecular and Cellular Biology 2013, 33(7):1345-1356.
24. Meyer A., Van de Peer Y. BioEssays 2005, 27(9):937-945.
25. Flicek, P.; et al. Ensembl 2013. Nucleic Acids Research 41, Database issue: D48-D55.
26. Lorenzen J.A., Dadabay C.Y., Fischer E.H. The Journal of Cell Biology 1995, 131(3):631-643.
27. Tiganis T., Flint A.J., et al. Journal of Biological Chemistry 1997, 272(34):21548-21557.
28. Lam M.H., Michell B.J., et al. Journal of Biological Chemistry 2001, 276(40):37700-37707.
29. Hutchins A.P., Poulain S., Miranda-Saavedra D. Blood 2012, 119(13):e110.
30. Chen R., et al. Cell 2012, 148(6):1293-1307.
31. Chepelev I., Wei G., Tang Q., Zhao K. Nucleic Acids Research 2009, 37(16):e106.
32. Langmead B., Trapnell C., Pop M., Salzberg S.L. Genome Biology 2009, 10(3):R25.
33. Trapnell C., Pachter L., Salzberg S.L. Bioinformatics 2009, 25(9):1105-1111.
34. Li B., Dewey C.N. BMC Bioinformatics 2011, 12(323).
35. Shields B.J., et al. Molecular and Cellular Biology 2013, 33(3):557-570.
36. Scharl M., et al. Inflammatory Bowel Diseases 2012, 18(5):900-912.
37. Shen G.Q., Abdullah K.G., Wang Q.K. Methods in Molecular Biology 2009, 578:293-306.
38. Reinius L.E., Acevedo N., Joerink M., Pershagen G., Dahlén S-E., et al. PLoS One 2012, 7(7):e41361.
39. Welte S., Baringhaus K.H., Schmider W., Muller G., Petry S., Tennagels N. Analytical Biochemistry 2005, 338:32-38.
40. Blanchetot C., Chagnon M., Dubé N., Hallé M., Tremblay M.L. Methods 2005, 35(1):44-53.
41. Kleppe M., et al. Nature Genetics 2010, 42(6):530-535.
42. Kleppe M., et al. Haematologica 2011, 96(11):1723-1727.